Psychedelic stocks, termed 'shroom stocks,' are gaining traction as treatments for mental disorders. Investor interest is growing as psychedelic companies progress through clinical trials. While ...

In a mountain town about three hours outside of Mexico City, I sat on the floor of a thatched-roof palapa with blankets wrapped around me as a facilitator (both a researcher and medicine woman ...